Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 6 studies | 38% ± 19% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 36% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 76% | 438.18 | 2018 / 2642 | 58% | 4.01 | 412 / 705 |
breast | 45% | 709.35 | 205 / 459 | 23% | 4.51 | 252 / 1118 |
adrenal gland | 21% | 33.04 | 55 / 258 | 19% | 1.61 | 44 / 230 |
lymph node | 0% | 0 | 0 / 0 | 28% | 1.30 | 8 / 29 |
pancreas | 11% | 6.09 | 37 / 328 | 8% | 0.23 | 14 / 178 |
esophagus | 12% | 13.06 | 167 / 1445 | 4% | 0.08 | 7 / 183 |
lung | 1% | 0.39 | 4 / 578 | 8% | 0.35 | 93 / 1155 |
intestine | 7% | 8.18 | 71 / 966 | 1% | 0.02 | 5 / 527 |
uterus | 7% | 7.25 | 12 / 170 | 1% | 0.05 | 5 / 459 |
spleen | 6% | 2.95 | 14 / 241 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 5% | 0.12 | 23 / 504 |
kidney | 3% | 1.75 | 3 / 89 | 0% | 0.01 | 3 / 901 |
thymus | 0% | 0.21 | 3 / 653 | 2% | 0.03 | 10 / 605 |
stomach | 0% | 0.16 | 1 / 359 | 2% | 0.09 | 5 / 286 |
skin | 2% | 0.95 | 29 / 1809 | 0% | 0.00 | 1 / 472 |
prostate | 0% | 0 | 0 / 245 | 1% | 0.31 | 6 / 502 |
adipose | 1% | 0.64 | 13 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 0% | 0.45 | 5 / 1335 | 0% | 0 | 0 / 0 |
ovary | 0% | 0 | 0 / 180 | 0% | 0.00 | 1 / 430 |
heart | 0% | 0.21 | 2 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 0% | 0 | 0 / 406 |
muscle | 0% | 0 | 0 / 803 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0 | 0 / 929 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0051260 | Biological process | protein homooligomerization |
GO_0042391 | Biological process | regulation of membrane potential |
GO_0060079 | Biological process | excitatory postsynaptic potential |
GO_1902476 | Biological process | chloride transmembrane transport |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0005886 | Cellular component | plasma membrane |
GO_0043204 | Cellular component | perikaryon |
GO_1902495 | Cellular component | transmembrane transporter complex |
GO_0043005 | Cellular component | neuron projection |
GO_0030425 | Cellular component | dendrite |
GO_0045202 | Cellular component | synapse |
GO_0045211 | Cellular component | postsynaptic membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0016935 | Cellular component | glycine-gated chloride channel complex |
GO_0004888 | Molecular function | transmembrane signaling receptor activity |
GO_0005231 | Molecular function | excitatory extracellular ligand-gated monoatomic ion channel activity |
GO_0016934 | Molecular function | extracellularly glycine-gated chloride channel activity |
GO_0030594 | Molecular function | neurotransmitter receptor activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0016594 | Molecular function | glycine binding |
GO_0022852 | Molecular function | glycine-gated chloride ion channel activity |
GO_0005254 | Molecular function | chloride channel activity |
Gene name | GLRA3 |
Protein name | Glycine receptor subunit alpha-3 Uncharacterized protein GLRA3 Glycine receptor alpha 3 subunit |
Synonyms | |
Description | FUNCTION: Glycine receptors are ligand-gated chloride channels. Channel opening is triggered by extracellular glycine . Channel characteristics depend on the subunit composition; heteropentameric channels display faster channel closure (By similarity). Plays an important role in the down-regulation of neuronal excitability (By similarity). Contributes to the generation of inhibitory postsynaptic currents (By similarity). Contributes to increased pain perception in response to increased prostaglandin E2 levels (By similarity). Plays a role in cellular responses to ethanol (By similarity). . |
Accessions | Q4W595 ENST00000274093.8 [O75311-1] O75311 Q9UPF3 ENST00000340217.5 [O75311-2] |